Plasma levels of neurogenic inflammation related neuropeptides in pediatric patients with community-acquired pneumonia and their potential diagnostic value in distinguishing viral and bacterial pneumonia

被引:1
|
作者
Bekdas, Mervan [1 ]
Saygi, Bilgi [1 ]
Kilinc, Yasemin Baranoglu [2 ]
Kilinc, Erkan [3 ]
机构
[1] Bolu Abant Izzet Baysal Univ, Fac Med, Dept Pediat, Bolu, Turkiye
[2] Bolu Izzet Baysal State Hosp, Dept Pediat, Bolu, Turkiye
[3] Abant Izzet Baysal Univ, Fac Med, Dept Physiol, Bolu, Turkiye
关键词
Community-acquired pneumonia; Children; Neurogenic inflammation; Neuropeptides; PEPTIDE; PROCALCITONIN; BIOMARKER; NEURONS;
D O I
10.1007/s00431-023-05417-y
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Neurogenic inflammation is involved in the development and progression of respiratory inflammatory diseases. However, its role in community-acquired pneumonia (CAP) remains unclear. We therefore aimed to investigate plasma levels of neurogenic inflammation-related neuropeptides, calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY), and procalcitonin (PCT) in pediatric patients with CAP and to assess their diagnostic value in viral and bacterial/mixed pneumonia. A total of 124 pediatric patients with CAP (1 month-18 years old) and 56 healthy children of similar ages were prospectively enrolled. The patients were classified as viral (n = 99) and bacterial/mixed (n = 25) pneumonia. Plasma levels of the peptides were quantified by ELISA. ROC analysis was performed to evaluate possible diagnostic value of the peptides. While plasma levels of CGRP, VIP and PCT were significantly higher in patients with CAP than in the control group, respectively, NPY levels were significantly lower. Moreover, plasma levels of all neuropeptides and PCT were significantly higher in bacterial pneumonia patients compared to viral pneumonia patients. ROC analysis revealed that CGRP, SP and NPY had a diagnostic value in distinguishing viral and bacterial/mixed pneumonia.Conclusions: Our findings suggest that these neuropeptides may be implicated in pediatric CAP. CGRP, SP and NPY together may be a promising candidate in distinguishing viral and bacterial/mixed pneumonia, however, for this, further studies are needed.What is Known:center dot Neurogenic inflammation contributes to the development and progression of respiratory inflammatory diseases such as chronic obstructive pulmonary disease and bronchial asthma.What is New:center dot Plasma levels of neurogenic inflammation related neuropeptides calcitonin gene-related peptide, substance P, vasoactive intestinal peptide and neuropeptide Y are changed in pediatric community-acquired pneumonia. Calcitonin gene-related peptide, substance P and neuropeptide Y are promising candidates in distinguishing viral and bacterial/mixed pneumonia.
引用
收藏
页码:1619 / 1627
页数:9
相关论文
共 50 条
  • [21] Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia
    Chang, Jer-Hwa
    Hung, Wen-Yueh
    Bai, Kuan-Jen
    Yang, Shun-Fa
    Chien, Ming-Hsien
    International Journal of Medical Sciences, 2016, 13 (09): : 673 - 679
  • [22] Diagnostic and Prognostic Value of Peripheral Neutrophil CD64 Index in Elderly Patients with Community-Acquired Pneumonia
    Li, Yan
    Zhang, Jing
    Wang, Suhang
    Cao, Jie
    CRITICAL REVIEWS IN IMMUNOLOGY, 2024, 44 (04)
  • [23] An international perspective on hospitalized patients with viral community-acquired pneumonia
    Radovanovic, Dejan
    Sotgiu, Giovanni
    Jankovic, Mateja
    Mahesh, Padukudru Anand
    Jorge Marcos, Pedro
    Abdalla, Mohamed I.
    Di Pasquale, Marta Francesca
    Gramegna, Andrea
    Terraneo, Silvia
    Blasi, Francesco
    Santus, Pierachille
    Aliberti, Stefano
    Reyes, Luis F.
    Restrepo, Marcos I.
    Noriega, Lorena
    Alvarado, Ezequiel
    Aman, Mohamed
    Labra, Lucia
    Karina Aruj, Patricia
    Attorri, Silvia
    Barimboim, Enrique
    Pablo Caeiro, Juan
    Garzon, Maria I.
    Hugo Cambursano, Victor
    Ceccato, Adrian
    Chertcoff, Julio
    Cordon Diaz, Ariel
    de Vedia, Lautaro
    Cristina Ganaha, Maria
    Lambert, Sandra
    Lopardo, Gustavo
    Luna, Carlos M.
    Gerardo Malberti, Alessio
    Morcillo, Nora
    Tartara, Silvina
    Pensotti, Claudia
    Pereyra, Betiana
    Gustavo Scapellato, Pablo
    Pablo Stagnaro, Juan
    Shah, Sonali
    Loetsch, Felix
    Thalhammer, Florian
    Anseeuw, Kurt
    Francois, Camille A.
    Van Braeckel, Eva
    Vincent, Jean Louis
    Djimon, Marcel Zannou
    Nouer, Simone Aranha
    Chipev, Peter
    Encheva, Milena
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2019, 60 : 54 - 70
  • [24] Outcomes of corticosteroid therapy in patients with viral community-acquired pneumonia
    Cilloniz, Catia
    Guzzardella, Amedeo
    Calabretta, Davide
    Gabarrus, Albert
    Marcos, Maria Angeles
    Torres, Antoni
    PNEUMONIA, 2024, 16 (01):
  • [25] Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia
    Viasus, Diego
    Garcia-Vidal, Carolina
    Simonetti, Antonella
    Manresa, Frederic
    Dorca, Jordi
    Gudiol, Francesc
    Carratala, Jordi
    JOURNAL OF INFECTION, 2013, 66 (05) : 415 - 423
  • [26] Diagnostic value of bronchoalveolar lavage in children with nonresponding community-acquired pneumonia
    Tsai, Chih-Min
    Wong, Kin-Sun
    Lee, Wei-Ju
    Hsieh, Kai-Sheng
    Hung, Pi-Lien
    Niu, Chen-Kuang
    Yu, Hong-Ren
    PEDIATRICS AND NEONATOLOGY, 2017, 58 (05) : 430 - 436
  • [27] Diagnostic performance of neutrophil CD64 in distinguishing between bacterial and mycoplasma community-acquired pneumonia in children
    Qui, Fei
    Liu, Jun
    Yang, Aiping
    Tu, Rongliang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 5365 - 5372
  • [28] Delafloxacin for the treatment of adult patients with community-acquired bacterial pneumonia
    Bassetti, Matteo
    Melchio, Monica
    Giacobbe, Daniele Roberto
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (05) : 649 - 656
  • [29] Differentiating Bacterial From Viral Etiologies in Pediatric Community-Acquired Pneumonia: The Quest for the Holy Grail Continues
    Florin, Todd A.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2021, 10 (12) : 1047 - 1050
  • [30] The potential economic value of sputum culture use in patients with community-acquired pneumonia and healthcare-associated pneumonia
    Asti, L.
    Bartsch, S. M.
    Umscheid, C. A.
    Hamilton, K.
    Nachamkin, I.
    Lee, B. Y.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (08) : 1038.e1 - 1038.e9